The Food and Drug Administration on Friday allowed the emergency use of Gilead's remdesivir that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The regulator cleared Gilead Science’s intravenous drug for hospitalized patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators.from IndiaTV: Google News Feed https://ift.tt/3bXqw70
Post a Comment